Page last updated: 2024-10-21

4,5,6,7-tetrabromo-2-azabenzimidazole and Sensitivity and Specificity

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Sensitivity and Specificity in 1 studies

4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor

Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)

Research Excerpts

ExcerptRelevanceReference
"Besides cardiovascular diseases, cancer represents the major cause of death in developed countries."1.36A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease. ( Götz, C; Gratz, A; Jose, J, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gratz, A1
Götz, C1
Jose, J1

Other Studies

1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Sensitivity and Specificity

ArticleYear
A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
    Journal of enzyme inhibition and medicinal chemistry, 2010, Volume: 25, Issue:2

    Topics: Casein Kinase II; Emodin; Enzyme Assays; Fluorescence; Fluorescence Resonance Energy Transfer; Human

2010